Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation
Background: Hypertriglyceridaemia (HTG) is an important risk factor for pancreatitis and cardiovascular disease (CVD), depending on severity. Hypertriglyceridaemia is common in human immunodeficiency virus (HIV) infection and is also a common complication of lopinavir/ritonavir (LPV/r). Objectives:...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2018-06-01
|
Series: | Southern African Journal of HIV Medicine |
Subjects: | |
Online Access: | https://sajhivmed.org.za/index.php/hivmed/article/view/766 |
_version_ | 1818545130931486720 |
---|---|
author | Wilhelm P. Greffrath Jesslee M. du Plessis Michelle Viljoen Marike Cockeran |
author_facet | Wilhelm P. Greffrath Jesslee M. du Plessis Michelle Viljoen Marike Cockeran |
author_sort | Wilhelm P. Greffrath |
collection | DOAJ |
description | Background: Hypertriglyceridaemia (HTG) is an important risk factor for pancreatitis and cardiovascular disease (CVD), depending on severity. Hypertriglyceridaemia is common in human immunodeficiency virus (HIV) infection and is also a common complication of lopinavir/ritonavir (LPV/r).
Objectives: To evaluate the risk of pancreatitis associated with HTG in patients six months post initiation of LPV/r-based therapy in a regional public hospital.
Methods: Triglyceride (TG), serum amylase (s-amylase) and CD4+ count values were retrospectively investigated six months post LPV/r-based initiation. Age, gender, previous antiretroviral regimen and period since HIV diagnosis were also recorded.
Results: The final sample consisted of 194 patients, 50 males and 144 females; mean (± standard deviation [s.d.]) age was 39.52 (± 9.98) years, and the mean (± s.d.) period since HIV diagnosis was 91.32 (± 25.18) months. Normal TG levels (< 1.70 mmol/L) were detected in only 55% of patients and the rest presented with some degree of HTG. The mean (± s.d.) TG for the entire sample was elevated at 1.94 (± 1.30) mmol/L with the mean (± s.d.) of the males at 2.36 (± 1.74) – statistically higher compared to the females at 1.79 (± 1.08) mmol/L (p = 0.034). No cases of pancreatitis were recorded and the time since HIV diagnosis did not indicate any statistically significant differences in the means of the TG, serum amylase or CD4 count values.
Conclusion: Triglyceride levels were not substantially elevated to induce pancreatitis at six months post initiation of LPV/r, but were elevated above the accepted upper normal limit of 1.70 mmol/L which may have implications for cardiovascular risk. |
first_indexed | 2024-12-11T22:57:31Z |
format | Article |
id | doaj.art-e5c6a36f948b4da7ad4b33675785eb62 |
institution | Directory Open Access Journal |
issn | 1608-9693 2078-6751 |
language | English |
last_indexed | 2024-12-11T22:57:31Z |
publishDate | 2018-06-01 |
publisher | AOSIS |
record_format | Article |
series | Southern African Journal of HIV Medicine |
spelling | doaj.art-e5c6a36f948b4da7ad4b33675785eb622022-12-22T00:47:11ZengAOSISSouthern African Journal of HIV Medicine1608-96932078-67512018-06-01191e1e610.4102/sajhivmed.v19i1.766590Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiationWilhelm P. Greffrath0Jesslee M. du Plessis1Michelle Viljoen2Marike Cockeran3KwaZulu-Natal Department of HealthMedicine Usage in South Africa (MUSA), North-West UniversityCentre of Excellence for Pharmaceutical Sciences, Division of Pharmacology, Faculty of Health Sciences, North-West University, South Africa; Pharmacology and Clinical Pharmacy, School of Pharmacy, Faculty of Natural Sciences, University of the Western CapeMedicine Usage in South Africa (MUSA), North-West UniversityBackground: Hypertriglyceridaemia (HTG) is an important risk factor for pancreatitis and cardiovascular disease (CVD), depending on severity. Hypertriglyceridaemia is common in human immunodeficiency virus (HIV) infection and is also a common complication of lopinavir/ritonavir (LPV/r). Objectives: To evaluate the risk of pancreatitis associated with HTG in patients six months post initiation of LPV/r-based therapy in a regional public hospital. Methods: Triglyceride (TG), serum amylase (s-amylase) and CD4+ count values were retrospectively investigated six months post LPV/r-based initiation. Age, gender, previous antiretroviral regimen and period since HIV diagnosis were also recorded. Results: The final sample consisted of 194 patients, 50 males and 144 females; mean (± standard deviation [s.d.]) age was 39.52 (± 9.98) years, and the mean (± s.d.) period since HIV diagnosis was 91.32 (± 25.18) months. Normal TG levels (< 1.70 mmol/L) were detected in only 55% of patients and the rest presented with some degree of HTG. The mean (± s.d.) TG for the entire sample was elevated at 1.94 (± 1.30) mmol/L with the mean (± s.d.) of the males at 2.36 (± 1.74) – statistically higher compared to the females at 1.79 (± 1.08) mmol/L (p = 0.034). No cases of pancreatitis were recorded and the time since HIV diagnosis did not indicate any statistically significant differences in the means of the TG, serum amylase or CD4 count values. Conclusion: Triglyceride levels were not substantially elevated to induce pancreatitis at six months post initiation of LPV/r, but were elevated above the accepted upper normal limit of 1.70 mmol/L which may have implications for cardiovascular risk.https://sajhivmed.org.za/index.php/hivmed/article/view/766Hypertriglyceridaemiapancreatitislopinavir/ritonavircardiovascular risk |
spellingShingle | Wilhelm P. Greffrath Jesslee M. du Plessis Michelle Viljoen Marike Cockeran Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation Southern African Journal of HIV Medicine Hypertriglyceridaemia pancreatitis lopinavir/ritonavir cardiovascular risk |
title | Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation |
title_full | Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation |
title_fullStr | Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation |
title_full_unstemmed | Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation |
title_short | Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation |
title_sort | hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir ritonavir initiation |
topic | Hypertriglyceridaemia pancreatitis lopinavir/ritonavir cardiovascular risk |
url | https://sajhivmed.org.za/index.php/hivmed/article/view/766 |
work_keys_str_mv | AT wilhelmpgreffrath hypertriglyceridaemiaandtheriskofpancreatitissixmonthspostlopinavirritonavirinitiation AT jessleemduplessis hypertriglyceridaemiaandtheriskofpancreatitissixmonthspostlopinavirritonavirinitiation AT michelleviljoen hypertriglyceridaemiaandtheriskofpancreatitissixmonthspostlopinavirritonavirinitiation AT marikecockeran hypertriglyceridaemiaandtheriskofpancreatitissixmonthspostlopinavirritonavirinitiation |